Clinical Trial: Ustekinumab for the Treatment of Giant Cell Arteritis

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Open Label Study to Test the Safety and Efficacy of Ustekinumab in Patients With Giant Cell Arteritis

Brief Summary: The purpose of this study is to determine whether ustekinumab is effective in the treatment of Giant Cell Arteritis (GCA)